169 related articles for article (PubMed ID: 21234675)
1. Antibodies to myelin P0 and ceramide perpetuate neuropathy in long standing treated leprosy patients.
Raju R; Devi SK; Mehervani C; Kumar AS; Meena AK; Reddy PP; Pranay P; Jain S; Archelos-Gracia JJ; Suneetha S; Suneetha LM
Neurochem Res; 2011 May; 36(5):766-73. PubMed ID: 21234675
[TBL] [Abstract][Full Text] [Related]
2. Anti-ceramide antibodies in leprosy: marker for nerve damage?
Singh K; Singh B; Ray P
J Infect Dev Ctries; 2010 Jun; 4(6):378-81. PubMed ID: 20601789
[TBL] [Abstract][Full Text] [Related]
3. Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).
Kvarnstrom M; Sidorova E; Nilsson J; Ekerfelt C; Vrethem M; Soderberg O; Johansson M; Rosen A; Ernerudh J
Clin Exp Immunol; 2002 Feb; 127(2):255-62. PubMed ID: 11876747
[TBL] [Abstract][Full Text] [Related]
4. A possible novel isoform of peripheral myelin P0 protein: a target antigen recognized by an autoantibody in a patient with malignant lymphoma and peripheral neuropathy.
Ishida K; Takeuchi H; Takahashi R; Yoshimura K; Yamada M; Mizusawa H
J Neurol Sci; 2001 Jul; 188(1-2):43-9. PubMed ID: 11489284
[TBL] [Abstract][Full Text] [Related]
5. Myelin protein zero and its antibody in serum as biomarkers of n-hexane-induced peripheral neuropathy and neurotoxicity effects.
Jia X; Liu Q; Zhang Y; Dai Y; Duan H; Bin P; Niu Y; Liu J; Zhong L; Guo J; Liu X; Zheng Y
Chin Med J (Engl); 2014; 127(8):1536-40. PubMed ID: 24762602
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteomics of the Mycobacterium leprae binding protein myelin P0: its implication in leprosy and other neurodegenerative diseases.
Vardhini D; Suneetha S; Ahmed N; Joshi DS; Karuna S; Magee X; Vijayalakshmi DS; Sridhar V; Karunakar KV; Archelos JJ; Suneetha LM
Infect Genet Evol; 2004 Mar; 4(1):21-8. PubMed ID: 15019586
[TBL] [Abstract][Full Text] [Related]
7. Anticeramide antibody and butyrylcholinesterase in peripheral neuropathies.
Sykam A; Gutlapalli VR; Tenali SP; Meena AK; Chandran P; Suneetha S; Suneetha LM
J Clin Neurosci; 2017 Aug; 42():204-208. PubMed ID: 28576432
[TBL] [Abstract][Full Text] [Related]
8. Implications of Serum Anti-Ceramide Antibodies and Interleukin 4 on Nerve Damage and Physical Impairments Among Leprotic Patients: A Case-Controlled Study.
Zaky M; Obaid Z; Khedr M; El-Sokkary H; Elsaie M
J Drugs Dermatol; 2022 Mar; 21(3):284-291. PubMed ID: 35254767
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.
Inglis HR; Csurhes PA; McCombe PA
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):419-22. PubMed ID: 17158557
[TBL] [Abstract][Full Text] [Related]
10. [Effect of 2,5-hexanedione on myelin protein zero in sciatic nerve and its antibody in serum of rats at different time points].
Liu Q; Zhao L; Duan H; Dai Y; Niu Y; Chen H; Liu Q; Bin P; Zheng Y
Wei Sheng Yan Jiu; 2010 May; 39(3):275-8. PubMed ID: 20568451
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the anti-neural antibodies in the sera of leprosy patients.
Eustis-Turf EP; Benjamins JA; Lefford MJ
J Neuroimmunol; 1986 Feb; 10(4):313-30. PubMed ID: 3511085
[TBL] [Abstract][Full Text] [Related]
12. Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis.
Archelos JJ; Roggenbuck K; Schneider-Schaulies J; Toyka KV; Hartung HP
J Neurol Sci; 1993 Jul; 117(1-2):197-205. PubMed ID: 7691994
[TBL] [Abstract][Full Text] [Related]
13. The role of antiperipheral nerve antibodies in nerve damage in leprosy.
Desikan P; Parkash O; Narang P
Lepr Rev; 1994 Sep; 65(3):222-30. PubMed ID: 8942152
[TBL] [Abstract][Full Text] [Related]
14. Detection of S-100 antigen and anti ceramide antibody in sera of leprosy patients with and without reaction.
Narayan R; Maheshwari PK; Desikan KV; Harinath BC
Indian J Lepr; 1997; 69(4):347-52. PubMed ID: 9474510
[TBL] [Abstract][Full Text] [Related]
15. Analysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India.
Jadhav R; Suneetha L; Kamble R; Shinde V; Devi K; Chaduvula MV; Raju R; Suneetha S; Nicholls PG; van Brakel WH; Lockwood DN
PLoS Negl Trop Dis; 2011 Mar; 5(3):e977. PubMed ID: 21408123
[TBL] [Abstract][Full Text] [Related]
16. Serum IgG antibodies to P0 dimer and 35 kDa P0 related protein in neuropathy associated with monoclonal gammopathy.
Favereaux A; Lagueny A; Vital A; Schmitter JM; Chaignepain S; Ferrer X; Labatut-Cazabat I; Vital C; Petry KG
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1262-6. PubMed ID: 12933931
[TBL] [Abstract][Full Text] [Related]
17. Childhood peripheral neuropathy with autoantibodies to myelin glycoprotein P0.
Ben Jelloun-Dellagi S; Dellagi K; Burger D; Ben Younes-Chennoufi A; Hentati FF; Steck A; Ben Hamida M
Ann Neurol; 1992 Nov; 32(5):700-2. PubMed ID: 1280408
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies specific to the integral membrane protein P0 of bovine peripheral nerve myelin.
Yoshimura K; Negishi T; Kaneko A; Sakamoto Y; Kitamura K; Hosokawa T; Hamaguchi K; Nomura M
Neurosci Res; 1996 May; 25(1):41-9. PubMed ID: 8808799
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
Khalili-Shirazi A; Atkinson P; Gregson N; Hughes RA
J Neuroimmunol; 1993 Jul; 46(1-2):245-51. PubMed ID: 7689591
[TBL] [Abstract][Full Text] [Related]
20. Serum antibodies against peripheral nervous system antigens in leprosy.
Chujor CS; Regele H; Bernheimer H; Meeker HC; Levis WR; Schwerer B
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):590-7. PubMed ID: 1724981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
